Notable Facts
→CFO of Horizon Therapeutics from 2014-2022, overseeing pharmaceutical company growth and eventual $28B acquisition by Amgen in 2022
→Held senior finance roles at OfficeMax (SVP Finance) and Alberto-Culver (VP Finance)
→Prior audit practice experience at KPMG LLP (1986-1993)
→Board member of Sagimet Biosciences (appointed April 2024)
→Trustee of Illinois Chapter of The Leukemia & Lymphoma Society
→500+ LinkedIn connections
→B.S. in Accountancy from University of Illinois at Urbana-Champaign, CPA
→Post-Horizon roles: Currently at Sagimet Biosciences; previously advised Horizon through May 2023